Expression of p120-catenin phosphorylation dead mutant leads to decreased tumor cell metastasis <i>in-vivo</i>. by Alisha M. Mendonsa (9033917)

“…(C) Weight in grams of primary tumor at 4 weeks post injection showed no significant difference between WT and S/T6A p120-catenin expressing tumors. Number of (D) surface lung metastases or (E) total number of tumors determined through H&E staining showing a decrease in metastatic ability of 4T1 cells expressing the S/T6A versus WT p120-catenin. …”

<i>N</i>-glycans which showed decreased relative abundance in cancer patient serum compared with normal volunteer. by Shih-Yun Guu (755060)

Inhibition of the <i>de novo</i> pyrimidine biosynthesis pathway decreases proliferation of temozolomide-sensitive and -resistant glioblasomta cells. by M. Carmen Lafita-Navarro (9652697)

Overexpression of CD39 in HEK293 cells and endothelial cells significantly decreases platelet activation <i>in vitro</i>. by Meike-Kristin Abraham (797370)

Human cochlin bound to <i>N</i>-sulfated heparin and mutations in DFNA9 patients decreased binding affinity. by Tomoko Honda (5732531)

“…(B) <i>N</i>-desulfated, <i>N</i>-acetylated heparin significantly decreased binding affinity for cochlin. …”

The expression of <i>c-Fos</i> is decreased in the dentate gyrus of HIWM trained rats as compared to RM or LIWM rats. by Mickaël Antoine Joseph (821433)

The Hh signaling pathway effectors are decreased in E14.5 <i>Fuz^−/−</i> mouse embryos. by Zichao Zhang (344301)

“…<p><b>A</b>) Immunofluorescence of Patched1 in sagittal sections of E14.5 <i>Fuz^+/−</i> heterozygous embryos. …”

<i>sox10</i> mutants have decreased intestinal transit and hyperpermeability, independent of intestinal microbially induced inflammation. by M. Kristina Hamilton (9162785)

Decreased accumulation of myeloid cells is accompanied with reduced parasite burden in <i>Fzd6</i>^-/- spleen. by Belma Melda Abidin (4336639)

Disruption of <i>ETHR</i> expression leads to decreased yolk deposition and reduced ovary size in SD-induced females. by Shuang Guo (294074)

The NK1-receptor antagonist ezlopitant significantly decreases voluntary intake of sucrose using the drinking in the dark model in mice. by Pia Steensland (362091)

“…<p>The highest dose of ezlopitant (15 mg/kg) decreased consumption of 5% sucrose (<b>A</b>). However, ezlopitant treatment failed to induce a significant decrease in ethanol consumption compared to vehicle (<b>B</b>). …”

RV infection decreases IRAK-1 protein levels in both BEAS-2B and primary airway epithelial cells. by Benjamin L. Unger (130418)

Reduced proliferation in ciliary regions of <i>Ftm</i>-deficient murine hearts and thickness decrease of <i>Ftm</i>-negative walls. by Christoph Gerhardt (383942)

Phagosomes from p110α knockdown cells show marked decreases in LAMP-1 acquisition and phagolysosome fusion. by Emily P. Thi (176454)

Small decreases in Ca²⁺ influx following exposure to JZL184 in isolated rat islets and INS-1 cells. by Charles A. Berdan (849879)

Expression of VGLUT1 increases while VGLUT2 decreases at individual presynaptic puncta during postnatal synapse development. by Corbett T. Berry (296520)

“…Similarly, the modest decrease in VGLUT2 was present regardless of whether all puncta (F, <i>left</i>), only VGLUT2-positive puncta (F, <i>middle</i>) or only VGLUT1- and VGLUT2-positive puncta (E, <i>right</i>) were analyzed. …”

PfCAF1ΔC has decreased gametocyte conversion and exflagellation compared to wild type NF54 parasites. by Kevin J. Hart (6282068)

Pharmacologic control of oxidative stress and inflammation determines whether diabetic glomerulosclerosis progresses or decreases: A pilot study in sclerosis-prone mice - Fig 1 by Fabrizio Grosjean (352916)

Pharmacologic control of oxidative stress and inflammation determines whether diabetic glomerulosclerosis progresses or decreases: A pilot study in sclerosis-prone mice - Fig 2 by Fabrizio Grosjean (352916)

RAP and LRP-1 silencing by siRNA decreased the level and density of lysosome in MCF-7R cells. by Aubery Henry (17060668)